Literature DB >> 17009308

Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation.

Lauren M Pachman1, Arthur Veis, Stuart Stock, Kathy Abbott, Frank Vicari, Pravin Patel, Diana Giczewski, Catherine Webb, Lyudmila Spevak, Adele L Boskey.   

Abstract

OBJECTIVE: Calcific deposits develop in 20-40% of children with juvenile dermatomyositis (juvenile DM), contributing to disease morbidity and mortality. This study was undertaken to define the structure and composition of these deposits and to characterize their association with chronic inflammation.
METHODS: We examined calcific deposits from 5 children with juvenile DM (2 boys and 3 girls). The crystal structure and mineral content of the deposits was analyzed by x-ray diffraction, Fourier transform infrared spectroscopy, and imaging. The protein content of the deposits, following solubilization, was assayed by Western blotting.
RESULTS: All 5 children had both a young age at disease onset (mean +/- SD 3.3 +/- 1.9 years) and, despite therapy, persistent cutaneous inflammation (mean +/- SD duration 81.3 +/- 58.7 months). The bone proteins, osteopontin, osteonectin, and bone sialoprotein, were identified in the protein extracts; the only mineral detected was hydroxyapatite, but the tissue was distinct from bone, with an extremely high mineral content and an irregular distribution of mineral.
CONCLUSION: These results indicate that chronic cutaneous inflammation may contribute to the formation of hydroxyapatite-containing pathologic calcifications in children with juvenile DM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009308      PMCID: PMC2329813          DOI: 10.1002/art.22158

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

2.  Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence.

Authors:  Rita K Bode; Marisa S Klein-Gitelman; Michael L Miller; Toula S Lechman; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2003-02-15

3.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Authors:  Lauren M Pachman; Rebecca Lipton; Rosalind Ramsey-Goldman; Eli Shamiyeh; Kathy Abbott; Eduardo P Mendez; Alan Dyer; Deborah Mc Curdy; Larry Vogler; Ann Reed; Gail Cawkwell; Lawrence Zemel; Christy Sandborg; Rafael Rivas-Chacon; Christine Hom; Norman Ilowite; Abraham Gedalia; Jonathan Gitlin; Michael Borzy
Journal:  Arthritis Rheum       Date:  2005-04-15

4.  Identification of specific calcium-binding noncollagenous proteins associated with glutaraldehyde-preserved bovine pericardium in the rat subdermal model.

Authors:  T A Gura; K L Wright; A Veis; C L Webb
Journal:  J Biomed Mater Res       Date:  1997-06-15

5.  Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Does infection influence plaque stability?

Authors:  B T Müller; R Huber; B Henrich; O Adams; G Berns; M Siebler; S Jander; W Müller; R Loncar; E Godehardt; W Sandmann
Journal:  Vasa       Date:  2005-08       Impact factor: 1.961

6.  Pathological calcification in juvenile dermatomyositis (JDM): microCT and synchrotron x-ray diffraction reveal hydroxyapatite with varied microstructures.

Authors:  S Stock; K Ignatiev; P Lee; K Abbott; L Pachman
Journal:  Connect Tissue Res       Date:  2004       Impact factor: 3.417

Review 7.  Calcinosis in rheumatic diseases.

Authors:  Nina Boulman; Gleb Slobodin; Michael Rozenbaum; Itzhak Rosner
Journal:  Semin Arthritis Rheum       Date:  2005-06       Impact factor: 5.532

8.  TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.

Authors:  L M Pachman; M R Liotta-Davis; D K Hong; T R Kinsella; E P Mendez; J M Kinder; E H Chen
Journal:  Arthritis Rheum       Date:  2000-10

9.  Duration of illness is an important variable for untreated children with juvenile dermatomyositis.

Authors:  Lauren M Pachman; Kathy Abbott; James M Sinacore; Lisa Amoruso; Alan Dyer; Rebecca Lipton; Norman Ilowite; Christine Hom; Gail Cawkwell; Andrew White; Rafael Rivas-Chacon; Yukiko Kimura; Linda Ray; Rosalind Ramsey-Goldman
Journal:  J Pediatr       Date:  2006-02       Impact factor: 4.406

10.  Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls.

Authors:  Adele L Boskey; David J Moore; Michael Amling; Ernesto Canalis; Anne M Delany
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

View more
  21 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 2.  FT-IR imaging of native and tissue-engineered bone and cartilage.

Authors:  Adele Boskey; Nancy Pleshko Camacho
Journal:  Biomaterials       Date:  2006-12-18       Impact factor: 12.479

3.  Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis.

Authors:  Takako Miyamae; Fumie Sano; Remi Ozawa; Tomoyuki Imagawa; Yoshiaki Inayama; Shumpei Yokota
Journal:  Pediatr Rheumatol Online J       Date:  2010-02-04       Impact factor: 3.054

4.  Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.

Authors:  Kelly A Rouster-Stevens; Gabrielle A Morgan; Deli Wang; Lauren M Pachman
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10       Impact factor: 4.794

5.  Calcification in a case of circumscribed myositis ossificans.

Authors:  Maria Ibarra; Pauline M Chou; Lauren M Pachman; Yong-Dong Zhao; Adele L Boskey
Journal:  J Rheumatol       Date:  2010-04       Impact factor: 4.666

Review 6.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

7.  Characterization of dystrophic calcification induced in mice by cardiotoxin.

Authors:  Yongdong Zhao; Annette L Urganus; Lyudmila Spevak; Sheela Shrestha; Stephen B Doty; Adele L Boskey; Lauren M Pachman
Journal:  Calcif Tissue Int       Date:  2009-08-20       Impact factor: 4.333

8.  The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.

Authors:  Roopa Seshadri; Brian M Feldman; Norman Ilowite; Gail Cawkwell; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2008-07-15

9.  Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

Authors:  H Gunawardena; L R Wedderburn; H Chinoy; Z E Betteridge; J North; W E R Ollier; R G Cooper; C V Oddis; A V Ramanan; J E Davidson; N J McHugh
Journal:  Arthritis Rheum       Date:  2009-06

10.  Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.

Authors:  Naomi Eidelman; Alan Boyde; Andrew J Bushby; Peter G T Howell; Jirun Sun; Dale E Newbury; Frederick W Miller; Pamela G Robey; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.